Form 4: Tempus AI COO Sells 5,000 Shares Under 10b5-1 Plan

Tempus AI's Chief Operating Officer, Ryan Fukushima, reported the sale of 5,000 shares of Class A Common Stock at $64.26 per share, executed under a pre-arranged 10b5-1 trading plan.

Summary

• Ryan Fukushima, Chief Operating Officer of Tempus AI, Inc. (TEM), reported a transaction involving the company's Class A Common Stock.
• On January 5, 2026, 5,000 shares of Class A Common Stock were disposed of at a price of $64.26 per share.
• This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Fukushima's spouse on March 4, 2025.
• Following the transaction, Mr. Fukushima directly beneficially owns 148,808 shares and indirectly beneficially owns 703,946 shares through his spouse.

Sentiment

Score: 5

Explanation: A neutral score. While an insider sale can sometimes be viewed negatively, the execution under a pre-planned 10b5-1 plan mitigates concerns that it's based on new, adverse information. It's a routine diversification or liquidity event for the insider.

Positives

• The transaction was executed under a Rule 10b5-1 trading plan, indicating a pre-scheduled sale rather than a reaction to recent company performance or news, which can mitigate negative market interpretations.

Negatives

• An insider sale, even if pre-planned, reduces the insider's direct equity stake and can sometimes be perceived negatively by the market, potentially leading to short-term price pressure.

Risks

• No specific risks are mentioned in this Form 4 filing beyond the general market perception of insider sales.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

Insider sales are a common occurrence across all industries, particularly in high-growth sectors like AI and healthcare technology where executives often hold substantial equity. The use of a Rule 10b5-1 plan is a standard and widely accepted mechanism for insiders to manage their personal financial planning, diversify holdings, or address liquidity needs in a pre-scheduled manner, thereby reducing the perception of trading on material non-public information.

Comparison to Industry Standards

• The utilization of a Rule 10b5-1 trading plan for insider stock sales is a standard and widely adopted practice among executives in publicly traded companies, including those in the technology and healthcare sectors like Tempus AI. This mechanism is designed to provide an affirmative defense against insider trading allegations by establishing a pre-determined schedule for transactions.
• Many executives at growth-oriented technology companies, similar to Tempus AI, routinely use 10b5-1 plans to manage their personal equity portfolios, often for diversification, estate planning, or liquidity purposes, rather than as a direct signal about the company's immediate operational performance or future prospects.

Related Party Transactions

• The transaction was executed under a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse, which is a common arrangement for managing indirect beneficial ownership.

Stakeholder Impact

• Shareholders: May interpret the insider sale as a slight negative, though the 10b5-1 plan context should temper such concerns. The overall impact on the company's valuation or strategic direction is likely minimal given the relatively small number of shares sold compared to total outstanding shares and the pre-planned nature.
• Employees, Customers, Suppliers, Creditors: Unlikely to be directly impacted by this routine insider transaction, as it pertains to personal equity management rather than operational or financial performance.

Key Dates

Recommendation

This Form 4 filing reports a routine insider stock sale executed under a pre-arranged 10b5-1 trading plan. Such transactions are typically for personal financial planning, diversification, or liquidity and do not usually signal a change in the company's fundamental prospects or management's confidence. Therefore, it provides no new information that would warrant a change in investment recommendation based solely on this filing. Investors should continue to hold based on their existing analysis of Tempus AI's fundamentals and market position.

Keywords

Tempus AI, TEM, Form 4, Insider Trading, Stock Sale, Ryan Fukushima, Chief Operating Officer, 10b5-1 Plan, Equity Transaction